Back to Search
ROBERT SMITH, M.D.
M.D.
Family Medicine Physician
NPI: 1508937723IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
10508(AL)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Class of 1981
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
NCT00287820COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline Effects In Schizophrenic Smokers
NCT00548470COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
NCT00802919COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Nicotine receptor partial agonists for smoking cessation.
PMID 37142273·Cochrane Database Syst Rev·2023
1-meta
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
PMID 26730716·PLoS One·2016
4-observational
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
PMID 23200554·Schizophr Res·2013
2-rct
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
PMID 22475524·Psychiatry Res·2012
2-rct
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
PMID 20457512·Schizophr Res·2010
2-rct
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
PMID 19251401·Schizophr Res·2009
3-trial
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
PMID 19814947·J Clin Psychiatry·2009
4-observational
In vitro macrophage response to polyethylene and polycarbonate-urethane particles.
PMID 19569215·J Biomed Mater Res A·2010
8-other
Orexin/hypocretin is necessary for context-driven cocaine-seeking.
PMID 19591850·Neuropharmacology·2010
7-preclinical
Geochemistry of inorganic nitrogen in waters released from coal-bed natural gas production wells in the Powder River Basin, Wyoming.
PMID 19452885·Environ Sci Technol·2009
8-other
Comparison of motility, recovery, and methyl-thiazolyl-tetrazolium reduction assays for use in screening plant products for anthelmintic activity.
PMID 19629527·Parasitol Res·2009
7-preclinical
Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
PMID 19656173·Eur J Neurosci·2009
7-preclinical
Inactivating the activated: identifying functions of specific neural networks.
PMID 19636350·Nat Neurosci·2009
7-preclinical
A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.
PMID 19532142·Mol Ther·2009
7-preclinical
Improving cosmesis of lupus pernio by excision and forehead flap reconstruction.
PMID 19508469·Clin Exp Dermatol·2009
5-case
Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study.
PMID 19535465·Autism·2009
8-other
Auxin transport-feedback models of patterning in plants.
PMID 19453483·Plant Cell Environ·2009
6-review
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
PMID 19628478·Hum Mol Genet·2009
7-preclinical
The relationship between the mid-point and most-prominent point on the labial curve of upper anterior teeth.
PMID 19672333·Open Dent J·2009
8-other
Intermedin is a new angiogenic growth factor.
PMID 19592612·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 68278 MAIN ST
BLOUNTSVILLE, AL 35031 - Phone
- (205) 429-4151
Quick Facts
- NPI
- 1508937723
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 45
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile